Synthesis of triazole derivatives as anti tubercular And anticancer agents
| dc.contributor.guide | Subhas S Karki | |
| dc.coverage.spatial | ||
| dc.creator.researcher | Arnika Das | |
| dc.date.accessioned | 2023-09-25T05:33:11Z | |
| dc.date.available | 2023-09-25T05:33:11Z | |
| dc.date.awarded | 2023 | |
| dc.date.completed | 2023 | |
| dc.date.registered | 2014 | |
| dc.description.abstract | Background: newlineCancer and tuberculosis are India s biggest health concerns. The National Cancer Registry newlineProgram 2022 reports an estimated 14,61,427 cancer patients in India by 2025 while WHO newlinefinds India as the country with the maximum number of tuberculosis cases. The government newlineof India vowed to eradicate TB by 2025. The chemotherapeutic agents available to treat newlinecancer bear one or the other untoward effects. At the same time, the emergence of multi- newlinedrug resistance Mycobacterium strains are limiting the effectiveness of existing anti- newlinetubercular drugs. newlineObjectives: newlineTo design and develop1,2,3-triazole analogs as a lead against cancer and tuberculosis. newline | |
| dc.description.note | ||
| dc.format.accompanyingmaterial | None | |
| dc.format.dimensions | ||
| dc.format.extent | ||
| dc.identifier.uri | http://hdl.handle.net/10603/513551 | |
| dc.language | English | |
| dc.publisher.institution | Faculty of Pharmacy | |
| dc.publisher.place | Belgaum | |
| dc.publisher.university | KLE University | |
| dc.relation | ||
| dc.rights | university | |
| dc.source.university | University | |
| dc.subject.keyword | Tuberculosis; 1,2,3-Triazole; Stilbene; Indole; Cytotoxicity; Molecular Docking; 1TUB; 6P8Q. | |
| dc.title | Synthesis of triazole derivatives as anti tubercular And anticancer agents | |
| dc.title.alternative | Synthesis of triazole derivatives as anti tubercular And anticancer agents | |
| dc.type.degree | Ph.D. |
Files
License bundle
1 - 1 of 1